DeepNewz, mobile.

People-sourced. AI-powered. Unbiased News.

Screenshot of DeepNewz app showing story detail view.

Screenshot of DeepNewz app showing story list view.

Padcev News

Pfizer and Merck’s Padcev Plus Keytruda Combo Shows Phase 3 Survival Benefits in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Patients

Pfizer and Merck’s Padcev Plus Keytruda Combo Shows Phase 3 Survival Benefits in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Patients

19

2 days ago

Latest stories

Aug 12, 2025
Aug 12, 2025
Canada
Pharma
Science
Pfizer and Merck’s Padcev Plus Keytruda Combo Shows Phase 3 Survival Benefits in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Patients
Authors
19
2 days ago

Join our channels

Get the latest stories live on any device.

WhatsApp
Top Stories
Join
Telegram
Top Stories
Join